APA
Jara-Sánchez C., Martín M., García-Sáenz J. A., Barnada A., Fernández-Aramburo A., López-Vega J. M., Pelegrí A., Alba E. & Casado A. (20030711). Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group. : Clinical breast cancer.
Chicago
Jara-Sánchez Carlos, Martín Miguel, García-Sáenz Jose A, Barnada Agustí, Fernández-Aramburo Antonio, López-Vega Jose M, Pelegrí Amadeu, Alba Emilio and Casado Antonio. 20030711. Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group. : Clinical breast cancer.
Harvard
Jara-Sánchez C., Martín M., García-Sáenz J. A., Barnada A., Fernández-Aramburo A., López-Vega J. M., Pelegrí A., Alba E. and Casado A. (20030711). Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group. : Clinical breast cancer.
MLA
Jara-Sánchez Carlos, Martín Miguel, García-Sáenz Jose A, Barnada Agustí, Fernández-Aramburo Antonio, López-Vega Jose M, Pelegrí Amadeu, Alba Emilio and Casado Antonio. Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group. : Clinical breast cancer. 20030711.